AVISI TECHNOLOGIES
Avisi Technologies develops VisiPlate, a next-generation, nanotechnology-enabled aqueous shunt intended to treat glaucoma.
AVISI TECHNOLOGIES
Industry:
Health Care Medical Device Nanotechnology
Founded:
2017-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.avisitech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.23 M USD
Technology used in webpage:
U.S. Server Location Site Kit
Similar Organizations
Dot
Dot is a pioneer in smart technology for the vision-impaired and the deafblind, helping them to lead more independent lives.
HAYA Therapeutics
HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.
Metalenz
Metalenz designs and sells metasurface optics for sensing in consumer electronics & automotive markets.
Nomic Bio
Nomic develops a proteomic technology platform designed to understand, detect, and treat diseases with DNA nanotechnology.
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Paragraf
Paragraf harnesses graphene’s unique properties to create the next generation of semiconductor devices.
PROCEPT BioRobotics
PROCEPT BioRobotics is a surgical robotics company that develops water-based robotic systems for prostate surgery.
Rapafusyn Pharmaceuticals
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
Current Advisors List
Current Employees Featured
Founder
Investors List
Life Sciences Greenhouse of Pennsylvania
Life Sciences Greenhouse of Pennsylvania investment in Seed Round - Avisi Technologies
Life Science Angels
Life Science Angels investment in Seed Round - Avisi Technologies
Kyto Technology and Life Science Inc
Kyto Technology and Life Science Inc investment in Seed Round - Avisi Technologies
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - Avisi Technologies
Gaingels
Gaingels investment in Seed Round - Avisi Technologies
Good Growth Capital
Good Growth Capital investment in Seed Round - Avisi Technologies
Mountain State Capital
Mountain State Capital investment in Seed Round - Avisi Technologies
Sunstone Management
Sunstone Management investment in Seed Round - Avisi Technologies
Accanto Partners
Accanto Partners investment in Seed Round - Avisi Technologies
MedVenture Partners
MedVenture Partners investment in Seed Round - Avisi Technologies
Official Site Inspections
http://www.avisitech.com
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avisi Technologies"
About - Avisi Technologies Inc.
For full-time employment and internship opportunities feel free to reach out to [email protected]. Supporting Our Vision: Partners in Progress. Avisi is supported by a network of venture …See details»
Avisi Technologies - Crunchbase Company Profile
Contact Email [email protected] Avisi Technologies develops VisiPlate, a next-generation, nanotechnology-enabled aqueous shunt intended to treat glaucoma. Products and ServicesSee details»
Developing a nanotechnology-enabled glaucoma device
Glaucoma is a group of eye diseases that damage the optic nerve and result in vision loss. The two most common types are primary open-angle glaucoma (POAG) and primary angle-closure …See details»
Avisi Technologies - LinkedIn
Avisi is developing a portfolio of ophthalmic treatments based on a novel metamaterial technology. Its flagship product, VisiPlate, is a nanotechnology-enabled implant to treat glaucoma.See details»
Avisi Technologies, Inc Company Profile | Redwood City, CA ...
Find company research, competitor information, contact details & financial data for Avisi Technologies, Inc of Redwood City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Avisi Technologies Company Profile - MedTech Innovator
MedTech Innovator is a 501(c)(3) nonprofit organization and the largest accelerator of medical technology companies in the world. Our mission is to improve the lives of patients by …See details»
Avisi (Therapeutic Devices) - PitchBook
Apr 1, 2021 Information on valuation, funding, cap tables, investors, and executives for Avisi (Therapeutic Devices). Use the PitchBook Platform to explore the full profile.See details»
Avisi Technologies - Ben Franklin Technology Partners
[email protected]. Rui Jing Jiang Co-Founder and CEO. Brandon Kao Co-Founder and CTO. Georgia Griggs VP of R&D. Ben Franklin Technology Partners of Southeastern Pennsylvania …See details»
Avisi Technologies - Overview, News & Similar companies
Avisi Technologies contact info: Phone number: (240) 439-8830 Website: www.avisitech.com What does Avisi Technologies do? Avisi was founded in 2017. As students studying business …See details»
Avisi Technologies, LLC | VentureRadar
"VisiPlate is a next-generation aqueous shunt that aims to treat glaucoma. VisiPlate is 20x thinner than a human hair. VisiPlate leverages an ultrathin nanoplate that is designed to achieve …See details»
Avisi Technologies - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Avisi Technologies Featured at LSI’s 2024 US Emerging Medtech …
Avisi Technologies returned to the 2024 US Emerging Medtech Summit with exciting updates on VisiPlate, their nanotechnology-enabled aqueous shunt for treating glaucoma. They generated …See details»
Avisi Technologies - Technical.ly
Avisitech.com; Overview Coverage Jobs Meet Avisi Technologies. This Pennovation Center-based medtech startup was founded at the University of Pennsylvania in 2017 by Rui Jing …See details»
Avisi Technologies - UCSF Rosenman Institute
Dec 15, 2023 Avisi Technologies is developing VisiPlate to treat glaucoma, the world’s leading cause of irreversible blindness. VisiPlate is a nanotechnology-enabled ocular implant for …See details»
Healthtech Leader of the Month: Rui Jing Jiang
Sep 26, 2023 Glaucoma, the world’s leading cause of irreversible blindness, affects 140 million people globally. The condition is characterized by a buildup of pressure in the eye that can …See details»
Life Sciences Greenhouse Investments Announces Funding for …
Jan 23, 2023 Firm Is Developing a Novel Nanotechnology-enabled Device for Treatment of Glaucoma Harrisburg, PA – January 23, 2023. Life Sciences Greenhouse Investments ( …See details»
Avisi Technologies - Craft
Avisi Technologies is a medical device company developing a nanoscale ocular implant to stop blindness in glaucoma patients. It offers VisiPlate, an aqueous shunt aimed at the treatment of …See details»
Press - Avisi Technologies Inc.
Some medtech start-ups begin with an inventor with a novel idea; others seek out an unmet clinical need looking for a solution. Avisi Technologies began with market research, that is, a …See details»
Avisi Technologies - Facebook
Avisi Technologies. 486 likes · 1 talking about this. Developing a nanotechnology enabled defense against blindness from glaucoma.See details»
VisiPlate® Aqueous Shunt Safety and Effectiveness data from VITA ...
May 14, 2024 Explore the forefront of glaucoma treatment with Avisi Technologies, Inc. Learn about their pioneering VisiPlate Aqueous Shunt, a nanotechnology-enabled implant designed …See details»